Inventor · disambiguated record
Xiaokai Li
Also filed as: LI XIAOKAI
8 granted patents·8 pending applications·11 citations·filing 2014–2024
78Inventor score
Top patents by PatentIndex Score
16 records- 0186US11845937B2RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2023·Granted Dec 19, 2023·1 cites·22 claims
- 0284US10221171B2Oxathiazole thiazolium Hsp 70 inhibitorsUNIV CALIFORNIA·Filed 2016·Granted Mar 5, 2019·4 cites·36 claims
- 0382US11597701B2Integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Mar 7, 2023·2 cites·24 claims
- 0480US10800780B2TDO2 InhibitorsGENENTECH INC·Filed 2016·Granted Oct 13, 2020·4 cites·17 claims
- 0579US12378558B2RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2024·Granted Aug 5, 2025·0 cites·19 claims
- 0668US12503696B2RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2024·Granted Dec 23, 2025·0 cites·16 claims
- 0767US2024076270A1Integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0865US11912997B2RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2023·Granted Feb 27, 2024·0 cites·30 claims
- 0965US2025223597A1Lipid conjugates for the delivery of therapeutic agents to cns tissueARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1057US2023407313A1Integrin targeting ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1156US2023265429A1Skeletal muscle delivery platforms and methods of use thereofARROWHEAD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1256US2023226193A1Lipid conjugates for the delivery of therapeutic agentsARROWHEAD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1356US2024175019A1Skeletal Muscle Delivery Platforms and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1451US12221610B2RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Feb 11, 2025·0 cites·20 claims
- 1546US2014275169A1Combination Therapies for Enhancing Protein DegradationFINLEY DANIEL J·Filed 2014·Application pending·0 cites
- 1641US2021093725A1Integrin targeting ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaokai Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →